Science Corporation implants its vision-restoring chip in its first Stargardt disease patient
TechCrunch 1 day ago 5
Science Corporation implanted its PRIMA vision-restoring chip into its first Stargardt disease patient. The implant was placed in May during the trial at the Sydney Eye Hospital, and the patient saw a letter at the first rehabilitation session and could read a word at the second. The company says PRIMA can expand into Stargardt-related vision restoration while it continues developing a broader brain-computer interface platform.